Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 study evaluating fractionated gemtuzumab ozogamicin for patients with measurable residual disease in acute myeloid leukemia is curre…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis [Phase 1]
This is a Phase 1 clinical trial evaluating rebecsinib in patients with relapsed/refractory secondary acute myeloid leukemia or high-risk my…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia [Phase 2]
This Phase 2 clinical trial compares treosulfan-based versus clofarabine-based conditioning regimens before donor allogeneic stem cell trans…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial update evaluating the combination of selinexor and venetoclax with chemotherapy in pediatric and young adult patients…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating a CD70-directed CAR T-cell therapy for pediatric hematologic malignancies is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial evaluating induction and consolidation with fludarabine, cytarabine, idarubicin, and venetoclax for acute myeloid leu…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML [Phase 1]
A Phase 1 trial evaluating the combination of ziftomenib and mezigdomide in adolescents and adults with relapsed or refractory acute myeloid…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases [Phase 2]
Phase 2 clinical trial evaluating a cord blood transplant using cyclophosphamide, fludarabine, and total-body irradiation in high-risk hemat…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia [Phase 1]
This is a Phase 1 trial update for a three-drug combination (ADI-PEG 20, venetoclax, and azacitidine) in adults with acute myeloid leukemia;…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of Revumenib and Mezigdomide in People With Leukemia [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of Revumenib and Mezigdomide for various forms of leukemia, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
A clinical trial update describing a study to identify barriers to allogeneic hematopoietic stem cell transplantation in patients with newly…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) [Phase 1]
Clinical trial update indicates CLN-049 is being studied for relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome in a Ph…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: CART123 + Ruxolitinib in Relapsed/Refractory AML [Phase 1]
A Phase 1 trial is evaluating CART123 CAR T therapy in combination with ruxolitinib for relapsed or refractory acute myeloid leukemia; the s…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies [Phase 1]
A Phase 1 study evaluating CG009301 for injection in adults with recurrent or refractory hematologic malignancies; recruitment is ongoing fo…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)
This document describes the REVIVE study, a clinical trial evaluating the safety and effectiveness of venetoclax in patients with acute myel…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Clinico-hematological and Coagulation Profiles in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Intensive Induction Chemotherapy .
A study protocol to assess clinico-hematological and coagulation profiles in newly diagnosed acute myeloid leukemia patients treated with in…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia [NA]
This clinical trial update describes a planned study of CLL-1–targeted CAR-T therapy followed by allogeneic hematopoietic stem cell transpla…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: CC-486 and Venetoclax for Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial evaluating CC-486 (oral azacitidine) in combination with venetoclax for acute myeloid leukemia, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation [Phase 1]
Phase 1 clinical trial evaluating base-edited CAR T cells in relapsed acute myeloid leukemia, with deep conditioning ahead of allogeneic ste…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission [Phase 1]
Phase 1 maintenance therapy trial evaluating decitabine alone or with venetoclax, gilteritinib, enasidenib, or ivosidenib in AML in remissio…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) [Phase 3]
A Phase 3 clinical trial update for Venetoclax in children with relapsed acute myeloid leukemia, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Clinical Study of Novel CAR-ITNK Cells Targeting CD70 and CLL1 for Refractory/Relapsed AML [EARLY_Phase 1]
A first-in-human early-phase trial of CAR-ITNK cells targeting CD70 and CLL1 for refractory/relapsed acute myeloid leukemia, not yet recruit…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML [EARLY_Phase 1]
This early phase 1 clinical trial evaluates a CAR-T therapy targeting CLL-1 (CLEC12A) in children with relapsed or refractory acute myeloid …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes [Phase 2]
This is a Phase 2 study evaluating intensity-modulated total marrow irradiation added to fludarabine/busulfan conditioning for allogeneic tr…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
A clinical trial is evaluating molecular features of acute myeloid leukemia patients after stem cell transplant to understand relapse events…